Cannabis Europa 2024 Has Successfully Wrapped Up!
We’re thrilled to have been part of such a dynamic event, packed with engaging discussions and valuable connections. The passion and innovation in the cannabis industry are truly inspiring.
Cannabis Europa brought together industry leaders, policymakers, investors, and advocates from around the globe. The event was a melting pot of ideas, showcasing the latest advancements, trends, and challenges in the medical cannabis sector.
Throughout the event, we participated in insightful panels and workshops that delved into critical topics such as regulatory frameworks, scientific research, market expansion, and patient access. These discussions not only highlighted the progress we’ve made but also underscored the work that still lies ahead to ensure safe and effective cannabis treatments are accessible to all who need them.
Networking with fellow professionals and visionaries in the field was an invaluable experience. We forged new partnerships and strengthened existing ones, paving the way for collaborative efforts that will drive the industry forward. The exchange of knowledge and expertise at Cannabis Europa was truly remarkable, and we are excited to implement the insights we gained into our own practices.
WE ARE EU-GMP CERTIFIED!

We are thrilled to announce that New Garden Pharma has achieved a significant milestone in our mission to uphold the highest quality and safety standards in the medical cannabis industry worldwide.
We have received EU GMP (European Good Manufacturing Practice) certification!
EU GMP certification is globally recognized for its stringent standards and commitment to product safety. This prestigious certification ensures that every medical cannabis product we produce meets the highest standards of quality, safety, and consistency.
As one of the few companies in Skopje, North Macedonia, to receive this certification, we are united in our dedication to professionalizing and standardizing the global medical cannabis sector. We proudly operate in key markets for medical cannabis, including Germany, the UK, Australia, and Israel.
With EU GMP certification, New Garden Pharma is uniquely positioned to meet the needs of pharmaceutical companies seeking top-tier, trusted suppliers. Our commitment to excellence and quality remains unwavering as we expand our reach, contributing to improved healthcare outcomes on a global scale.
We are excited about the future and the positive impact we can make together in the world of medical cannabis.